Altimmune Inc (ALT)

EBITDA Margin

-298787.10%

TTM · Period ending:

ALT logo

ALT EBITDA Margin

Latest reported-298787.10%
ALT TTM EBITDA Margin (61.98% → -298787.10%)
High-resolution chart · PNG

ALT ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Altimmune Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-298,787.0968%
-245,200%
-212,258.5366%
-418,580%
-440,130%
-453,760%
-474,060%
-195,028.8462%
-24,239.1198%
-22,072.6829%
-20,225.1174%
-27,816.4875%
99,169.9605%
106,808.4405%
125,870.1%
-2,585.76%
-2,755.934%
-2,566.5568%
-1,933.0092%
-2,337.5082%
-1,052.5512%
-984.9643%
-716.6225%
-705.1954%
-919.6778%
-459.5313%
-339.6516%
-553.656%
-359.863%
-401.4737%
-584.9656%
-375.363%
-590.385%
-693.7932%
-613.2892%
-626.4218%
-486.1586%
-234.0363%
-190.4971%
-147.7642%
-76.3148%
-108.2835%
-20.2687%
-38.5584%
-70.83%
-43.4244%
-93.5603%
-93.8679%
-72.5014%
-74.2722%
-56.9081%
-34.4417%
-20.9183%
-17.1791%
-22.9721%
-22.3435%
-41.164%
-48.254%
-45.8268%
-50.2302%
-37.5123%
-52.3607%
-85.2531%
-100.4448%
-116.8378%
-106.6644%
-90.6662%
-91.7468%
-66.7588%
-8.7576%
-6.8139%
-9.1685%
-11.9396%
-64.8703%
-76.2056%
-53.2201%
-90.58%
-273.2838%
-131.5971%
-145.7364%
61.98%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.